A first-class medical deferral for ADHD and Ulcerative Colitis does not represent the end of an aviation career path, but it does mark the beginning of a more complex administrative process with the FAA's Aerospace Medical Certification Division. A deferral is categorically distinct from a denial: the Aviation Medical Examiner (AME) lacked the authority at the office level to make a certification determination and forwarded the case to the FAA Civil Aerospace Medical Institute (CAMI) in Oklahoma City for further review. The applicant will receive a formal letter outlining what additional documentation — typically neuropsychological testing, specialist evaluations, and medical records — is required before any final determination is made. For aspiring airline pilots, understanding this distinction is foundational; many certificated airline and corporate pilots hold Special Issuance medicals for conditions far more acute than what this applicant presents.
On the ADHD question specifically, the FAA has an established Special Issuance pathway, but the process is demanding. The agency requires a comprehensive neuropsychological evaluation battery, documentation of functional history, and — critically — a medication washout period, generally 90 days off any stimulant medication before testing is conducted. This applicant ceased stimulant use in March 2026, placing the timeline close to or at that threshold as of early June. The childhood diagnosis adds complexity primarily in terms of documentation requirements, not disqualification per se. What the FAA is evaluating is whether ADHD currently impairs cognitive function in ways relevant to aviation safety, not whether a diagnosis existed decades ago. Applicants who demonstrate stable functioning without medication and who perform within normal limits on standardized cognitive testing have successfully obtained first-class medicals through this pathway.
The Ulcerative Colitis deferral is, in many respects, the more straightforward of the two to navigate. UC is a certifiable condition under FAA standards, and three or more years of documented, consistent remission is a genuinely favorable clinical profile for certification purposes. The FAA's primary concerns with inflammatory bowel disease center on unpredictable acute episodes, the potential for incapacitation, and certain immunosuppressive medications that carry their own certification implications. If the applicant's remission is well-documented and the medications in use are on the FAA's acceptable list, the UC component of this deferral may resolve with submission of specialist records and a straightforward gastroenterology status letter. Biologics and some newer UC therapies require individual FAA review, but many are now accepted under Special Issuance.
For pilots and aviation operators following these cases, this situation reflects a broader structural challenge in the FAA medical certification pipeline that has received increased scrutiny amid the ongoing pilot shortage. The Special Issuance process — while designed to protect safety — can take months to resolve, creates uncertainty for career-track candidates, and often requires costly neuropsychological and specialist evaluations that fall entirely on the applicant. Aviation advocacy organizations including AOPA's Medical Certification Services and the Pilot's Bill of Rights 2 framework have pressed for faster adjudication timelines and greater transparency in how ADHD cases are evaluated, given that the neuroscience around ADHD management has evolved considerably since the FAA's original protocols were established. Regional airlines and Part 141 flight training programs that recruit career-transition candidates increasingly encounter medical deferral situations at the screening stage, and some have begun advising prospective students to pursue medical certification before enrolling in training rather than after.
The practical guidance for any aspiring pilot in this position is consistent: engage an aviation medical consultant or attorney who specializes in FAA certification before responding to the CAMI letter, do not submit disorganized or incomplete documentation, and obtain the neuropsychological evaluation from a practitioner familiar with FAA standards. The process is navigable. Numerous commercial airline pilots hold Special Issuance certificates for ADHD, Crohn's disease, UC, and a range of other chronic conditions that are managed and stable. The deferral represents a procedural gate, not a verdict.